News

02 Jun: LSO supports delay of federal drug pricing rules implementation

Life Sciences Ontario applauds the federal government’s recent decision to delay the implementation of the Patented Medicines Regulations to January 1, 2021 as part of the response to the COVID-19 crisis. This measure will help the Canadian life sciences sector remain unwaveringly focused on developing vaccines, treatments, and other tools to fight…

19 Mar: How LSO Members are combating the spread of COVID-19

LSO put out a call to our members requesting insights on how companies are working together to combat the rapid spread of the novel COVID-19 virus. Below are some examples of how we, as a community are helping to control the outbreak. Member Announcements Amgen Canada: Amgen will provide its…

03 Feb: New federal drug pricing rules are already delaying medicine launches and costing jobs in Canada, survey reveals

To help measure the impacts of the federal government’s new price controls for patented medicines in Canada, Life Sciences Ontario commissioned Research Etc., an established Toronto research firm, to conduct an anonymous survey of pharmaceutical and other life sciences leaders. The survey, which drew on data from 46 respondents including leaders…

10 Jan: MEMBER ANNOUNCEMENT: adMare BioInnovations and Accel-Rx Unite to Advance the Canadian Life Sciences Sector

Vancouver, Canada – January 9, 2020: With a shared vision to be a catalyst for Canadian life sciences leading the world, adMare BioInnovations, Canada’s Global Life Sciences Venture (adMare), and Accel-Rx, Canada’s Health Sciences Accelerator (Accel-Rx), announced today they are bringing their respective capabilities and resources together under adMare to…

09 Dec: New data demonstrates that federal price controls on medicines are already driving decisions to delay or not launch new therapies in Canada, reduce clinical trial investments and stall compassionate access and patient support programs

Life Sciences Ontario commissioned Research Etc., an established Toronto research firm, to conduct a survey of pharmaceutical and other life sciences leaders on the Canadian price regulations policy environment. Preliminary results of the survey are now available, drawing on 23 responses from unique organizations representing Canadian and global pharma leaders….

19 Nov: Sizing up Canada’s biomedical field- The Globe and Mail

Canadian researchers have given the world insulin, pacemakers and the discovery of stem cells, and are making headway in a number of biomedical fields, including artificial intelligence, medical imaging, quantum computing and cannabis-based treatments. Aside from research and innovation, the potential for economic success in the biomedical field is massive,…